These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 600197)

  • 61. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
    Ronco E; Migueres ML; Vacheron F; Guenounou M
    Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Review of epidemic aminoglycoside resistance worldwide.
    Mayer KH
    Am J Med; 1986 Jun; 80(6B):56-64. PubMed ID: 3089005
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
    Price KE; DeFuria MD; Pursiano TA
    J Infect Dis; 1976 Nov; 134 SUPPL():S249-61. PubMed ID: 62814
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin].
    Juvin ME; Drugeon HB; Caillon J; Pirault JL
    Pathol Biol (Paris); 1987 May; 35(5):461-5. PubMed ID: 3302848
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
    Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
    Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rapid development of resistance of gentamicin, tobramycin and amikacin by E. coli 07.
    Humble MW; Bettelheim KA
    N Z Med J; 1978 May; 87(612):366. PubMed ID: 353599
    [No Abstract]   [Full Text] [Related]  

  • 68. [Evaluation of in vitro activity of 3 aminoglycosides: sisomicin, tobramycin and gentamycin].
    Grima P
    G Ital Chemioter; 1978; 25(1):49-51. PubMed ID: 751849
    [No Abstract]   [Full Text] [Related]  

  • 69. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract]   [Full Text] [Related]  

  • 70. An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage.
    Muscato JJ; Wilbur DW; Stout JJ; Fahrlender RA
    J Antimicrob Chemother; 1991 May; 27 Suppl C():1-7. PubMed ID: 1906860
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.
    Murray BE; Moellering RC
    Ann Intern Med; 1982 Feb; 96(2):176-80. PubMed ID: 7036812
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Antibacterial activity of tobramycin on enterobacteria. Present aspects of resistance factors].
    Witchitz J
    Nouv Presse Med; 1974 Apr; 3(0):43-6. PubMed ID: 4837114
    [No Abstract]   [Full Text] [Related]  

  • 73. [Aminoside sensitivity of bacteria isolated in 1984 at the military hospital complex in the Paris region].
    Meyran M; Buisson Y; Saliou P; Levagueresse R; Santiago M; Thabaut A
    Pathol Biol (Paris); 1987 May; 35(5):457-60. PubMed ID: 3302847
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early effects of gentamicin, tobramycin, and amikacin on the human kidney.
    De Broe ME; Paulus GJ; Verpooten GA; Roels F; Buyssens N; Wedeen R; Van Hoof F; Tulkens PM
    Kidney Int; 1984 Apr; 25(4):643-52. PubMed ID: 6482168
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
    Husson MO; Izard D; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):325-7. PubMed ID: 3459642
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center.
    Gerding DN; Larson TA
    Am J Med; 1985 Jul; 79(1A):1-7. PubMed ID: 4025364
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dissemination of Genes Encoding Aminoglycoside-Modifying Enzymes and armA Among Enterobacteriaceae Isolates in Northwest Iran.
    Ghotaslou R; Yeganeh Sefidan F; Akhi MT; Asgharzadeh M; Mohammadzadeh Asl Y
    Microb Drug Resist; 2017 Oct; 23(7):826-832. PubMed ID: 28151044
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
    Stratton CW; Weeks LS; Tausk F
    J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
    Phillips I; King A; Shannon K
    Am J Med; 1986 Jun; 80(6B):48-55. PubMed ID: 3728534
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins.
    Appleby DH; John JF
    Nephron; 1982; 30(4):341-4. PubMed ID: 7110465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.